Global Pharmaceutical Group *** GLOBAL NAPI PHARMACEUTICALS (GNP) is a local investment project of pharmaceutical formulations production in Egypt. In addition to production of GNP products, license agreements were established with multinational pharmaceutical companies, of them, MSD, Sanofi, Novartis, Stada, Elerte, SUN ,Cipla and others. GNP products are covering a wide range of therapeutic areas, with 130 local brands in tablets, capsules, solutions, syrups, ointments, creams, gels, and suppositories. GNP products are produced with the GMP standards. GNP is awarded ISO 9001 for quality, SO 14001 for environment and ISO 17025 for quality lab accreditation certificates. GNP was inspected, registered and the products were marketed in Yemen, Sudan, Tanzania, Uganda, Kenya and Eastern Europe (CIS). The company was also inspected and accepted by Romanian Health authorities for European GMP (PIC/s) *Global Pharmaceutical Industries (GPI) is established, designated for sterile injectable products; in the form of vials and ampoule in solution and lyophilized products. The products were in the market since November 2011. Also Pfizer, Amoun, SUN, IDI, EVA pharm, CIPLA and others are in contract manufacturing agreements with GPI for production of their injectable products. Around 30 brands are now in the market. GPI was inspected and approved by Romanian Health Authorities for European GMP (PIC/s), as well as Sudan and Yemen Health Authorities. * Global Advanced Pharmaceuticals (GAP) is a mega project in Egypt, composed of 6 modules of production for different pharmaceutical forms, Solid Dosage forms, Liquids, Ophthalmic Preparations, Large Volume Intravenous Fluids, Cephalosporin and Oncology products. The first phase of production, the Solid Dosage forms (Capsules and Tablets) and Blow-Fill-Seal (BFS) line, CPHI 2021 Milan booth No.5B36...